In our investments, we focus on addressing high and unmet medical needs and improving the quality of patients’ lives.
Our 2022 ESG & Impact Report illustrates the progress that the companies in our portfolios have made and provides insights on our approach to ESG and impact monitoring. Publishing this report, together with our efforts in supporting a sustainable global financial system by being signatory to the Principles for Responsible Investment, demonstrates that we are committed to ensuring that we live up to our mission of Impacting the Future of Medicine. For more than a decade, we have been enforcing principles of good governance and environmental and social management in our portfolio companies.
You can read the report here.